4//SEC Filing
Schroeder Timothy j 4
Accession 0001213900-23-057083
CIK 0001711754other
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 4:05 PM ET
Size
5.6 KB
Accession
0001213900-23-057083
Insider Transaction Report
Form 4
Inmune Bio, Inc.INMB
Schroeder Timothy j
Director
Transactions
- Sale
Common Stock
2023-07-12$11.01/sh−10,000$110,085→ 82,187 total(indirect: See Footnote)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 22, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares of common stock were sold in multiple transactions ranging from $11.00 to $11.10, inclusive. The reporting person undertakes to provide to Inmune Bio Inc., any security holder of Inmune Bio Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above.
- [F3]These shares of common stock are held by CTI Holdings, a company of which Mr. Schroeder is the majority shareholder. Mr. Schroeder has voting and investment control over these shares.
Documents
Issuer
Inmune Bio, Inc.
CIK 0001711754
Entity typeother
Related Parties
1- filerCIK 0001767226
Filing Metadata
- Form type
- 4
- Filed
- Jul 13, 8:00 PM ET
- Accepted
- Jul 14, 4:05 PM ET
- Size
- 5.6 KB